202 related articles for article (PubMed ID: 838398)
21. High titre of antibody to hepatitis B core antigen detected by immune adherence haemagglutination in HBsAg-positive acute hepatitis.
Ikegami F; Takasu S; Jo K; Miyakawa Y; Tsuda F; Mayumi M
Hepatogastroenterology; 1982 Aug; 29(4):142-3. PubMed ID: 7129336
[TBL] [Abstract][Full Text] [Related]
22. [Prevalence of the surface antigen of the hepatitis type B virus (HBsAg) in chronic hepatic disease].
Ocaña Andrade E; Valverde Castañeda N; Garrido Palma J; Carrillo Cambero JL
Rev Gastroenterol Mex; 1985; 50(1):19-22. PubMed ID: 4089439
[No Abstract] [Full Text] [Related]
23. Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma.
Chen DS; Sung JL; Lai MY
Hepatogastroenterology; 1981 Dec; 28(6):288-91. PubMed ID: 6284625
[TBL] [Abstract][Full Text] [Related]
24. Antibodies to non-structural hepatitis C virus antigens: a link with liver disease activity?
Gessoni G; Manoni F
Eur J Med; 1992 Sep; 1(5):288-94. PubMed ID: 1285245
[TBL] [Abstract][Full Text] [Related]
25. Antibody to hepatitis B core antigen in patients with hepatocellular carcinoma.
Kubo Y; Okuda K; Hashimoto M; Nagasaki Y; Ebata H
Gastroenterology; 1977 Jun; 72(6):1217-20. PubMed ID: 192626
[TBL] [Abstract][Full Text] [Related]
26. Studies on circulating immune complexes of the liver disease. 4. Clq binding activity.
Arima T; Narumoto J; Shimomura H; Suwaki K; Kunishi K; Yasuhara T; Nagashima H
Gastroenterol Jpn; 1980; 15(1):27-32. PubMed ID: 6153628
[TBL] [Abstract][Full Text] [Related]
27. Tissue markers of hepatitis B virus infection in hepatocellular carcinoma and cirrhosis.
Craxi A; Pasqua P; Giannuoli G; Di Stefano R; Simonetti RG; Pagliaro L
Hepatogastroenterology; 1984 Apr; 31(2):55-9. PubMed ID: 6327478
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B virus serological markers in Africans with liver cirrhosis and hepatocellular carcinoma.
Coursaget P; Chiron JP; Barres JL; Barin F; Cottey P; Tortey E; Yvonnet B; Diop B; MBoup S; Diop-Mar I
IARC Sci Publ; 1984; (63):181-98. PubMed ID: 6085625
[TBL] [Abstract][Full Text] [Related]
29. Viral antibody titres in HBs antigen-positive and -negative chronic active hepatitis.
Crimmins FB; Adams D; Ross M; Ash G; Thomas HC; Sherlock S
Scand J Gastroenterol; 1980; 15(1):107-12. PubMed ID: 6966067
[TBL] [Abstract][Full Text] [Related]
30. Correlation between titer of antibody to hepatitis B core antigen and presence of viral antigens in the liver.
Kojima M; Udo K; Takahashi Y; Yoshizawa H; Tsuda F; Itoh Y; Miyakawa Y; Mayumi M
Gastroenterology; 1977 Oct; 73(4 Pt 1):664-7. PubMed ID: 330306
[TBL] [Abstract][Full Text] [Related]
31. [e/Anti-e system in liver disease].
Resta ML; Freni MA; Berlinghieri G; Ajello A; Crinò M; Ferraù O
Boll Soc Ital Biol Sper; 1980 Oct; 56(20):2123-8. PubMed ID: 7459125
[TBL] [Abstract][Full Text] [Related]
32. Immunological aspects of cryoprecipitates from the sera of chronic HBsAg carriers.
Tiku ML; Beutner KR; Ogra PL
Clin Exp Immunol; 1979 Apr; 36(1):54-62. PubMed ID: 466862
[TBL] [Abstract][Full Text] [Related]
33. The role of the hepatitis B virus infection in patients with chronic hepatitis in Argentina.
Tanno H; Fay O; Findor J; Igartua EB; Roncoroni M; Gerety RJ; Vyas GN
J Med Virol; 1978; 3(2):119-23. PubMed ID: 731225
[TBL] [Abstract][Full Text] [Related]
34. Status and significance of testing for hepatitis B surface antigen and surface antibody.
Zanetti AR; Bedarida G; Ferroni P; D'Agostino F; Bianchi V
J Virol Methods; 1980 Dec; 2(1-2):71-83. PubMed ID: 7014582
[TBL] [Abstract][Full Text] [Related]
35. Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigen.
Schalm SW; Summerskill WH; Gitnick GL; Elveback LR
Gut; 1976 Oct; 17(10):781-6. PubMed ID: 793956
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B surface antigen and antibody. A prospective study in asymptomatic drug abusers.
Stimmel B; Vernace S; Schaffner F
JAMA; 1975 Dec; 234(11):1135-8. PubMed ID: 810605
[TBL] [Abstract][Full Text] [Related]
37. Persistence of hepatitis B e antigen for a long period after the clearance of hepatitis B surface antigen.
Tamura I; Shimase K; Ichimura H; Kurimura O; Kaneto E; Tsuchie H; Kurimura T
Acta Virol; 1985 Dec; 29(6):505-8. PubMed ID: 2869663
[TBL] [Abstract][Full Text] [Related]
38. Radioimmunoassay inhibition method for confirming the specificity of positive hepatitis B surface antigen reactions and for survey of antibodies to the antigen.
Forghani B; Schmidt NJ; Lennette EH
Vox Sang; 1977; 32(3):125-30. PubMed ID: 857418
[TBL] [Abstract][Full Text] [Related]
39. [Antibodies against hepatitis B virus in chronic non-alcoholic HBsAg-negative hepatopathies].
Moreira Vicente VF; Simón Marco MA; Pascasio Acevedo JM; Ruiz del Arbol Olmos L; Larraona Moreno JL; González Martín JA; Aguilera Musso D; Barcena Marugan R; Bueno Vallejo R
Med Clin (Barc); 1984 Mar; 82(12):522-30. PubMed ID: 6738151
[No Abstract] [Full Text] [Related]
40. [Evaluation of an immunoenzymatic method for the simultaneous determination of HBsAg and anti-HBs].
Tanzi E; Perin S; De Paschale M; Cometti R; Ferroni P
Quad Sclavo Diagn; 1985 Jun; 21(2):190-8. PubMed ID: 3909206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
